<?xml version="1.0" encoding="UTF-8"?>
<ref id="B144-pharmaceuticals-12-00157">
 <label>144.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Giulietti</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Righetti</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Cianfruglia</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Šabanović</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Armeni</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Principato</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Piva</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>To accelerate the Zika beat: Candidate design for RNA interference-based therapy</article-title>
  <source>Virus Res.</source>
  <year>2018</year>
  <volume>255</volume>
  <fpage>133</fpage>
  <lpage>140</lpage>
  <pub-id pub-id-type="doi">10.1016/j.virusres.2018.07.010</pub-id>
  <pub-id pub-id-type="pmid">30031046</pub-id>
 </element-citation>
</ref>
